| Entry |
|
|---|
| Name |
Carisoprodol (JAN/USP/INN);
Soma (TN) |
|---|
| Product |
|
|---|
| Generic |
CARISOPRODOL (A-S Medication Solutions), CARISOPRODOL (A-S Medication Solutions), CARISOPRODOL (Advanced Rx Pharmacy of Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Asclemed USA), CARISOPRODOL (Asclemed USA), CARISOPRODOL (Aurobindo Pharma Limited), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Chartwell RX), CARISOPRODOL (Direct_Rx), CARISOPRODOL (Direct_Rx), CARISOPRODOL (Directrx), CARISOPRODOL (Golden State Medical Supply), CARISOPRODOL (Ingenus Pharmaceuticals), CARISOPRODOL (Medsource Pharmaceuticals), CARISOPRODOL (Northwind Pharmaceuticals), CARISOPRODOL (Nostrum Laboratories), CARISOPRODOL (NuCare Pharmaceuticals), CARISOPRODOL (NuCare Pharmaceuticals), CARISOPRODOL (Oxford Pharmaceuticals), CARISOPRODOL (PD-Rx Pharmaceuticals), CARISOPRODOL (PD-Rx Pharmaceuticals), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Quality Care Products), CARISOPRODOL (REMEDYREPACK), CARISOPRODOL (REMEDYREPACK), CARISOPRODOL (Rising Pharma Holdings), CARISOPRODOL (ScieGen Pharmaceuticals), CARISOPRODOL (Vensun Pharmaceuticals), CARISOPRODOL (Wallace Pharmaceuticals), CARISOPRODOL (Wilshire Pharmaceuticals), CARISOPRODOL TABLETS, USP, 350 MG (Granulation Technology), CARISOPRODOL TABLETS, USP, 350 MG (PD-Rx Pharmaceuticals) |
|---|
| Formula |
C12H24N2O4
|
|---|
| Exact mass |
260.1736
|
|---|
| Mol weight |
260.33
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01974 Centrally acting muscle relaxant
DG01973 Carbamate muscle relaxant
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
|
|---|
| Remark |
|
|---|
| Efficacy |
Skeletal muscle relaxant |
|---|
| Comment |
Carbamate derivative
|
|---|
| Metabolism |
Enzyme: CYP2C19 [HSA: 1557]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
M03BA Carbamic acid esters
M03BA02 Carisoprodol
D00768 Carisoprodol (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Skeletal Muscle Relaxants
Carisoprodol
D00768 Carisoprodol (JAN/USP/INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01974 Centrally acting muscle relaxant
DG01973 Carbamate muscle relaxant
D00768 Carisoprodol
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D00768 Carisoprodol
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00768
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00768
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 N1a N 10.4300 -8.4000
2 C7a C 11.6424 -7.7000
3 O7a O 12.8549 -8.4000
4 C1b C 14.0673 -7.7000
5 C1d C 15.2797 -8.4000
6 C1b C 16.4922 -7.7000
7 O7a O 17.7046 -8.4000
8 C7a C 18.9170 -7.7000
9 N1b N 20.1295 -8.4000
10 C1c C 21.3419 -7.7000
11 O6a O 11.6424 -6.3002
12 C1b C 15.2797 -9.7999
13 C1a C 15.2797 -6.7900
14 C1b C 16.4774 -10.4914
15 O6a O 18.9170 -6.3001
16 C1a C 21.3419 -6.3000
17 C1a C 22.5604 -8.4035
18 C1a C 16.4775 -11.8997
BOND 17
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 2 11 2
11 5 12 1
12 5 13 1
13 12 14 1
14 8 15 2
15 10 16 1
16 10 17 1
17 14 18 1
|
|---|
|
